Home › Tyme Technologies, Inc. Receives FDA Acceptance Of Investigational New Drug Application For Oncology Drug Candidate, SM-88
 

Keywords :   


Tyme Technologies, Inc. Receives FDA Acceptance Of Investigational New Drug Application For Oncology Drug Candidate, SM-88

2015-11-03 04:55:30| drugdiscoveryonline News Articles

Tyme Technologies, Inc., a research and development company operating through its wholly-owned subsidiary, Tyme Inc., focused on development and eventual commercialization of oncology products, announced recently that the U.S

Tags: application drug technologies acceptance

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
More »